customer service software

Global Crohns Disease Diagnostic and Therapeutic Market

  • Published Date: 29 Apr 2018
  • Number of Pages: 231
  • Category: Healthcare and Medical
  • Country: Global

Crohns disease is a chronic inflammatory disease that can affect any part of the gastrointestinal tract from mouth to anus. The disease can cause significant lifestyle sacrifices and suffering and millions of dollars are spent in related health-care cost every year. The diagnosis of Crohns disease is mainly done through a combination of tests like Tests for anemia or infection and Fecal occult blood test. Currently, there is no cure available for Crohns disease, and there is no one treatment that works for everyone. The medical treatment aims to reduce the inflammation that triggers the signs and symptoms and improve long-term prognosis by limiting complications.

Market Dynamics

The continuous increase in prevalent cases of Crohns Disease across the world leads to the rise in the global Crohns disease diagnostic and therapeutic market. Further, an improved access to pharmacological therapies in China and India and continued uptake of selected biologic brands are the main market drivers. However, major barriers to the growth of the Crohns disease include- brand erosion following the patent expiry of the market-leading therapies, the complex pathogenesis of the disease, which creates an additional challenge in demonstrating clinical efficacy during clinical development and creation of challenging environment for new market entrants due to the already established biologics market.

Market Segmentation

The market is segmented on the basis of chronic autoimmune diseases that cause intestinal inflammation: Crohns disease (CD) and ulcerative colitis (UC). Further, the classification is done on the type of procedures and drugs used. Based on procedures, the market is segmented into colonoscopy, flexible sigmoidoscopy, computerized tomography (CT), magnetic resonance imaging (MRI), capsule endoscopy, double-balloon endoscopy and small bowel imaging. Further on the basis of drug type the market is classified into antibiotics, anti-diarrheal, immune system suppressors, pain relievers, and anti-inflammatory drugs. to cope with the various symptoms associated with the disease like anti-inflammatory drugs, immunosuppressive drugs, and antipyretics to reduce pain.

Regional/Geographic Analysis

Crohns disease diagnostic and therapeutic market has enormous opportunities around the world. The major markets include- the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. Focusing on country dynamics, Canada and the emerging markets of China and India will also play a key role in driving growth in the long term. For the forecasted period the US will account for the major share, followed by the 5EU and Japan. The higher sales numbers for the US can be attributed to the higher prices of pharmaceuticals and the greater diagnosed prevalence of Crohns disease in the region, as well as the high annual cost of therapy (ACOT) of J&Js Stelara and the anticipated ACOT of AbbVies risankizumab in the US market.

Key Players

The global Crohns disease diagnostic and therapeutic market is mainly controlled by firms such as J&Js Remicade, AbbVies Humira, Takedas alpha4beta7 inhibitor, Entyvio, Johnson & Johnsons (J&Js) interleukin (IL)-12/23 inhibitor, Stelara, Remicade (infliximab) and Humira (adalimumab).

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe

> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe

> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage

Publisher Name : Market Litmus

Global sarcopenia treatment market is valued approximately USD 2208.4 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period

View Report

The global market size of Skull Operating Rack is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit -

Cick Here